Legislation watch

Search all years.

2011 House Bill 1517: Requiring comparable coverage for patients who require orally administered anticancer medication
Introduced by Rep. Laurie Jinkins (Tacoma) (D) on January 25, 2011
Requires equitable cost sharing for cancer patients no matter the form of medication they receive. This act requires health plans for public employees to cover oral and intravenous cancer-growth medications in a comparable manner. This act takes effect January 1, 2012.   Official Text and Analysis.
Referred to the House Health Care & Wellness Committee on January 25, 2011
Referred to the House Rules Committee on February 17, 2011
Amendment offered by Rep. Laurie Jinkins (Tacoma) (D) on March 4, 2011
To change the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list.
The amendment passed by voice vote in the House on March 4, 2011
Amendment offered by Rep. Joe Schmick (Colfax) (R) on March 4, 2011
To limit the comparable coverage requirement for selfadministered anticancer drugs to health plans that cover selfadministered chemotherapy drugs, instead of health carriers that cover chemotherapy. States that the act does not require health plans to use self administered medication as a replacement for other cancer medications. Makes changes to the effect statement.
The amendment failed by voice vote in the House on March 4, 2011
Passed 80 to 17 in the House on March 4, 2011.
    See Who Voted "Yes" and Who Voted "No".
To require health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility.
Received in the Senate on March 7, 2011
Referred to the Senate Health & Long-Term Care Committee on March 7, 2011
Amendment offered in the Senate on March 22, 2011
To add a requirement for each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer medication as required by this act must report to the Health Committees of the Legislature by November 1, 2013, with a summary of their cost experience.
The amendment passed by voice vote in the Senate on March 22, 2011
Referred to the Senate Rules Committee on March 22, 2011
Passed 43 to 2 in the Senate on April 6, 2011.
    See Who Voted "Yes" and Who Voted "No".
Changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer medication as required by this act must report to the Health Committees of the Legislature by November 1, 2013, with a summary of their cost experience.
Received in the House on April 13, 2011
Passed 79 to 17 in the House on April 13, 2011.
    See Who Voted "Yes" and Who Voted "No".
House concurred with Senate amendments. This bill changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer.
Signed by Gov. Christine Gregoire on April 22, 2011
Changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer.

Comments